Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xcellara
- Development stage
- Unknown
- Lead developer
- BioAdaptives
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Xcellara is a dietary supplement developed and marketed by BioAdaptives, Inc. as a "Stem Cell Activator." It is a nutraceutical formulation composed of natural ingredients, including Aphanizomenon flos-aquae (AFA) blue-green algae, spirulina, astragalus, and cordyceps. The product is designed to promote the mobilization of hematopoietic stem and progenitor cells from the bone marrow into the systemic circulation to support overall wellness and repair. Xcellara serves as the base formula for a broader platform of organ-targeted wellness products, such as XcellaraHeart for cardiovascular health. Although the company cites a human randomized, double-blind, placebo-controlled clinical trial showing an increase in circulating stem cells, the product is not FDA-approved to diagnose, treat, cure, or prevent any disease.
- Brand names
- XcellaraXcellaraHeartXcellaraJointXcellaraNeuralXcellaraDermalXcellaraLongevityXcellaraStress
- Other names
- Stem Cell Activator
Beyond the preview
Go deeper on Xcellara.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xcellara.